Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $142,179,299.35
- Sept. 15, 2025
- Ltd Chione
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 20, 2018 | CEO | 10,000 | $14.79 | Sell | $147,900.00 | |
Feb. 16, 2018 | EVP | 2,500 | $15.01 | Sell | $37,525.00 | |
Feb. 7, 2018 | Insider | 10,000 | $12.50 | Sell | $125,000.00 | |
Feb. 7, 2018 | EVP | 1,500 | $13.00 | Sell | $19,500.00 | |
Jan. 18, 2018 | CEO | 10,000 | $10.09 | Sell | $100,900.00 | |
Jan. 8, 2018 | Insider | 10,000 | $10.08 | Sell | $100,800.00 | |
Dec. 18, 2017 | CEO | 10,000 | $9.16 | Sell | $91,600.00 | |
Dec. 12, 2017 | SVP | 27,042 | $10.28 | Sell | $277,991.76 | |
Dec. 7, 2017 | Insider | 10,000 | $10.39 | Sell | $103,900.00 | |
Nov. 7, 2017 | SVP | 4,958 | $11.25 | Sell | $55,777.50 | |
Oct. 2, 2017 | SVP | 1,500 | $12.00 | Sell | $18,000.00 | |
Oct. 2, 2017 | Director | 2,000 | $12.00 | Sell | $24,000.00 | |
Sept. 15, 2017 | SVP | 2,000 | $11.00 | Sell | $22,000.00 | |
Sept. 15, 2017 | Director | 2,882 | $11.00 | Sell | $31,702.00 | |
Sept. 11, 2017 | Director | 118 | $11.00 | Sell | $1,298.00 | |
Aug. 29, 2017 | SVP | 2,195 | $10.00 | Sell | $21,950.00 | |
June 26, 2017 | SVP | 805 | $10.03 | Sell | $8,074.15 | |
Nov. 14, 2016 | Insider | 3,309 | $10.06 | Sell | $33,288.54 | |
June 23, 2016 | Major Shareholder | 18,824 | $8.03 | Sell | $151,156.72 | |
June 13, 2016 | Major Shareholder | 7,074 | $8.51 | Sell | $60,199.74 | |
June 9, 2016 | Major Shareholder | 45,541 | $9.21 | Sell | $419,432.61 | |
June 7, 2016 | Major Shareholder | 40,000 | $9.24 | Sell | $369,600.00 | |
June 2, 2016 | Major Shareholder | 17,855 | $9.65 | Sell | $172,300.75 | |
June 1, 2016 | Major Shareholder | 74,664 | $9.61 | Sell | $717,521.04 | |
May 31, 2016 | Major Shareholder | 17,096 | $9.66 | Sell | $165,147.36 | |
May 27, 2016 | Major Shareholder | 40,000 | $9.58 | Sell | $383,200.00 | |
May 26, 2016 | Major Shareholder | 46,122 | $9.73 | Sell | $448,767.06 | |
May 23, 2016 | Major Shareholder | 93,932 | $8.54 | Sell | $802,179.28 | |
May 18, 2016 | Major Shareholder | 63,800 | $8.15 | Sell | $519,970.00 | |
May 16, 2016 | Major Shareholder | 10,400 | $8.01 | Sell | $83,304.00 | |
May 11, 2016 | Major Shareholder | 31,868 | $8.24 | Sell | $262,592.32 | |
Dec. 8, 2015 | Director | 15,000 | $15.01 | Sell | $225,150.00 | |
April 7, 2015 | EVP | 3,000 | $31.81 | Buy | $95,430.00 | |
April 2, 2015 | Director | 3,000 | $29.31 | Buy | $87,930.00 | |
April 2, 2015 | CFO | 5,000 | $29.71 | Buy | $148,550.00 | |
Jan. 12, 2015 | CEO | 50,000 | $33.00 | Sell | $1,650,000.00 | |
Jan. 12, 2015 | Director | 45,454 | $33.00 | Buy | $1,499,982.00 | |
Jan. 12, 2015 | Insider | 25,000 | $33.00 | Sell | $825,000.00 | |
Dec. 2, 2014 | Director | 10,000 | $43.52 | Sell | $435,200.00 | |
Dec. 1, 2014 | Major Shareholder | 278,115 | $41.92 | Sell | $11,658,580.80 | |
Nov. 25, 2014 | Major Shareholder | 242,800 | $42.40 | Sell | $10,294,720.00 | |
Nov. 19, 2014 | Major Shareholder | 65,968 | $40.09 | Sell | $2,644,657.12 | |
Nov. 12, 2014 | Major Shareholder | 164,100 | $42.83 | Sell | $7,028,403.00 | |
Nov. 11, 2014 | Major Shareholder | 54,100 | $42.51 | Sell | $2,299,791.00 | |
Nov. 10, 2014 | Major Shareholder | 65,000 | $43.40 | Sell | $2,821,000.00 | |
Nov. 10, 2014 | Director | 5,000 | $45.05 | Sell | $225,250.00 | |
Nov. 6, 2014 | Major Shareholder | 272,784 | $42.11 | Sell | $11,486,934.24 | |
Oct. 29, 2014 | Director | 3,500 | $40.05 | Sell | $140,175.00 | |
Sept. 26, 2014 | Major Shareholder | 50,000 | $42.54 | Sell | $2,127,000.00 | |
Sept. 24, 2014 | Major Shareholder | 22,498 | $40.32 | Sell | $907,119.36 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Deepika Pakianathan, Stuart Poulton, Sohanya Roshan Cheng, Jatin Shah, Reshma Rangwala, Ran Frenkel, Kristin Abate, Michael Mano, Garen G Bohlin, Stephen Mitchener, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on Sept. 15, 2025.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.